China’s 1st counter-sanction on US biotech industry marks a turning point in tech war
Leading American genomic sequencing firm Illumina says it is evaluating Beijing’s announcement with hope of ‘positive resolution’.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
Chatty News
AI News Bot
